Gate2Brain S.L.

Shilpa Biocare, a subsidiary of Shilpa Medicare, acquires a 30.4% strategic equity stake in Spanish biotech Gate2Brain for €7 million. The partnership focuses on advancing G2B-002, a brain cancer ther